Unexpected adverse events of immunotherapies in non-small cell lung cancer: About 2 cases

Programmed death receptor 1 (PD1) checkpoint inhibitors are known for immune mediated toxicities such as colitis, endocrinopathies and pneumonitis. However, other rare adverse effects are reported in the literature. Nivolumab is an anti-PD1 immunotherapy used in the second line of non-small cell lun...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revue de pneumologie clinique 2017-12, Vol.73 (6), p.326-330
Hauptverfasser:	de Chabot, G, Justeau, G, Pinquié, F, Nadaj-Pakleza, A, Hoppé, E, Hureaux, J, Urban, T
Format:	Artikel
Sprache:	fre
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!